Abbott announced the restart of formula production at its Sturgis, Michigan plant after meeting U.S. Food and Drug Administration (FDA) requirements, according to a company statement.
Abbott begins production of EleCare which will be available to consumers starting June 20.
A statement from the company said: “We are also working hard to complete the steps necessary to restart production of Similac and other formulas will do so as soon as possible. We understand the urgent need for infant formula, and our top priority is to get high-quality, safe formula into the hands of families across America. We will increase production as quickly as possible while meeting all requirements. We are committed to safety and quality and will do everything in our power to regain the trust that parents, caregivers and health care providers have given us for 130 years.
The Utah Department of Health said a significant amount of infant formula had “entered the state, particularly into ‘warehouse’ stores” in the past five days. The following image is from the Winco in Layton.
Over the past 5 days, a significant amount of infant formula has arrived as it is, especially to “warehouse” stores.
The first photo is of the Winco in Layton.
We see good quantities of ready-to-serve as is, and we are starting to see more sensitive formulas (second photo). pic.twitter.com/v9PPqj8UP3
— Utah Department of Health (@UtahDepOfHealth) June 6, 2022
According to UDOH, their teams worked to request additional products for Associated Foods from Abbott, Mead Johnson and Gerber.
For up-to-date information on the formula shortage, click here.
UDOH said in a tweet: “As always, to the moms in Utah helping each other find a formula. You are rock stars! Social media activity by posting formula photos and locations helps thousands of families across the state.